Potential Involvement of LncRNAs in Cardiometabolic Diseases

Genes (Basel). 2023 Jan 13;14(1):213. doi: 10.3390/genes14010213.

Abstract

Characterized by cardiovascular disease and diabetes, cardiometabolic diseases are a major cause of mortality around the world. As such, there is an urgent need to understand the pathogenesis of cardiometabolic diseases. Increasing evidence suggests that most of the mammalian genome are transcribed as RNA, but only a few percent of them encode for proteins. All of the RNAs that do not encode for proteins are collectively called non-protein-coding RNAs (ncRNAs). Among these ncRNAs, long ncRNAs (lncRNAs) are considered as missing keys to understand the pathogeneses of various diseases, including cardiometabolic diseases. Given the increased interest in lncRNAs, in this study, we will summarize the latest trend in the lncRNA research from the perspective of cardiometabolism and disease by focusing on the major risk factors of cardiometabolic diseases: obesity, cholesterol, diabetes, and hypertension. Because genetic inheritance is unavoidable in cardiometabolic diseases, we paid special attention to the genetic factors of lncRNAs that may influence cardiometabolic diseases.

Keywords: cardiovascular; genetics; lncRNA; metabolism.

Publication types

  • Review

MeSH terms

  • Animals
  • Cardiovascular Diseases* / genetics
  • Cardiovascular Diseases* / pathology
  • Diabetes Mellitus* / genetics
  • Hypertension*
  • Mammals / genetics
  • Obesity / genetics
  • RNA, Long Noncoding* / genetics
  • RNA, Long Noncoding* / metabolism

Substances

  • RNA, Long Noncoding

Grants and funding

This research received no external funding.